why choose us

First received: June 24, 2024

Clinical Trial: A Study to Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chronic Kidney Disease

Study Type: INTERVENTIONAL


Official Title: Single and Multiple Dose Escalation Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAY 3283142 Given as Immediate Release (IR) Tablets in Chinese Healthy Particip

Brief Summary: Researchers are looking for a better way to treat people who have chronic kidney disease (CKD) or non-proliferative diabetes retinopathy (NPDR).CKD is a long-term condition in which the ability of the kidneys to work decreases over time.It is often caused by high blood glucose levels.NPDR is another condition in which high blood glucose levels cause damage to the blood vessels of the retina, which is a tissue at the back of the eyes.The study drug BAY3283142 works by activating a protein called soluble guanylate…

Read more